Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C2 | P52895 | 2/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.43 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.42 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.39 |
| ▸ | PTGES | O14684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5154201 | 0.91 | POLB (0.41) | AKR1C2ABCB1PTGDR2PTGDRMAPT | |
| SCHEMBL9017484 | 0.90 | AKR1C2 (0.56) | AKR1C2PTGS2PTGS1MAPTKDM4E | |
| SCHEMBL4691290 | 0.90 | PTGS1 (0.44) | AKR1C2ABCB1PTGS2PTGS1PTGDR2 | |
| SCHEMBL6013496 | 0.90 | AKR1C2 (0.49) | AKR1C2PTGS2PTGS1MAPTKDM4E | |
| SCHEMBL18765238 | 0.89 | POLB (0.38) | AKR1C2ABCB1PTGS2PTGS1PTGDR2 | |
| SCHEMBL5809614 | 0.89 | MEN1 (0.40) | AKR1C2ABCB1PTGS2PTGDR2PTGDR | |
| SCHEMBL5499426 | 0.88 | AKR1C2 (0.48) | AKR1C2PTGS2PTGS1PTGDR2PTGDR | |
| SCHEMBL5154300 | 0.87 | POLB (0.38) | AKR1C2PTGS2PTGDR2PTGDRMAPT | |
| SCHEMBL5806535 | 0.86 | POLB (0.41) | PTGS1MAPTGAAPOLBALDH1A1 | |
| SCHEMBL5496301 | 0.85 | AKR1C2 (0.46) | AKR1C2ABCB1PTGDR2PTGDRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0006223-A1 | Crystalline sodium and potassium indomethacin and their trihydrates, process for preparing and pharmaceutical compositions containing the same | MERCK & CO. INC. (US) | 1980-01-09 | — | — | EP | claimed |
| WO-2024105529-A1 | CHEMICAL DISBUDDING OF LIVESTOCK | MASSEY UNIVERSITY (NZ) | 2024-05-23 | — | — | WO | disclosed |
| WO-2023134733-A1 | TREATMENT OF SIGNS, SYMPTOMS AND/OR COMPLICATIONS OF VIRAL, BACTERIAL, PROTOZOAL, AND/OR FUNGAL INFECTIONS BY HIGH PENETRATION PRODRUGS | TECHFIELDS PHARMA CO., LTD. (CN) | 2023-07-20 | — | — | WO | disclosed |
| EP-3938385-A1 | ENGINEERED CELLS FOR PRODUCTION OF INDOLE-DERIVATIVES | Danmarks Tekniske Universitet (DK) | 2022-01-19 | — | — | EP | disclosed |
| WO-2020187739-A1 | ENGINEERED CELLS FOR PRODUCTION OF INDOLE-DERIVATIVES | DANMARKS TEKNISKE UNIVERSITET (DK) | 2020-09-24 | — | — | WO | disclosed |
| WO-2018148721-A1 | HIGHLY SELECTIVE AKR1C3 INHIBITORS AND METHODS OF USE THEREOF | TEXAS TECH UNIVERSITY SYSTEM (US) | 2018-08-16 | — | — | WO | disclosed |
| WO-2015097667-A2 | A COMPOSITION, PROCESS OF PREPARATION OF SAID COMPOSITION, KIT AND A METHOD OF TREATING CANCER | CELLWORKS GROUP, INC., (US) | 2015-07-02 | — | — | WO | disclosed |
| EP-2459186-A1 | OPHTHALMIC SOLUTION FOR PROTECTING INTERNAL STRUCTURES OF THE EYEBALL AGAINST UV-A RAYS OR FOR THE TREATMENT OF KERATOCONUS WITH A TRANS-EPITHELIAL CROSS-LINKING TECHNIQUE | Troisi, Salvatore (IT) | 2012-06-06 | — | — | EP | disclosed |
| EP-2323976-A1 | ARYL ALKYL CARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION AND DOSAGE FORMS | Shasun Chemicals And Drugs Limited (IN) | 2011-05-25 | — | — | EP | disclosed |
| WO-2011001228-A1 | ARYL ALKYL CARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION AND DOSAGE FORMS | SHASUN CHEMICALS AND DRUGS LIMITED (IN) | 2011-01-06 | — | — | WO | disclosed |
| EP-0544819-A1 | INDOLE DERIVATIVES WHICH INHIBIT LEUKOTRIENE BIOSYNTHESIS. | ABBOTT LAB (US) | 1993-06-09 | — | — | EP | disclosed |
| EP-0473655-A4 | DIVALENT METAL SALTS OF INDOMETHACIN | — | 1992-05-20 | — | — | EP | disclosed |
| EP-0473655-A1 | DIVALENT METAL SALTS OF INDOMETHACIN. | BIOCHEMICAL VETERINARY RES (AU) | 1992-03-11 | — | — | EP | disclosed |
| EP-0090972-A2 | Indazole derivatives | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-10-12 | — | — | EP | disclosed |
| EP-0051193-A1 | The use of N-halogenophenyl-benzisothiazoles | A. Nattermann & Cie. GmbH (DE) | 1982-05-12 | — | — | EP | disclosed |
| EP-0050385-A1 | Piridoxine derivatives, a process for their preparation and related pharmaceutical compositions | D and D S.r.l. (IT) | 1982-04-28 | — | — | EP | disclosed |
| EP-0017169-A1 | Improved anti-inflammatory combinations having reduced ulcerogenicity | MERCK & CO. INC. (US) | 1980-10-15 | — | — | EP | disclosed |
| EP-0010061-A1 | Pharmaceutical preparations containing a mollusc extract | Mc Farlane, Stuart John (NZ) | 1980-04-16 | — | — | EP | disclosed |
| EP-0006223-A1 | Crystalline sodium and potassium indomethacin and their trihydrates, process for preparing and pharmaceutical compositions containing the same | MERCK & CO. INC. (US) | 1980-01-09 | — | — | EP | disclosed |
| US-4119638-A | Thio-ester of 1 (p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid | G. D. SEARLE & CO. (US) | 1978-10-10 | — | — | US | disclosed |